While the maintenance of a Market Outperform rating suggests continued confidence in Macrogenics' fundamentals and potential for growth, the reduction in the price target may reflect adjustments in market conditions, expected performance, or both. This could lead to mixed reactions in the short term, as investors weigh the positive rating against the lowered price expectations.